Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan Yoon Cheah

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pathology|May 27, 2015
Diffuse large B-cell lymphoma with microsatellite instability developing in the setting of Muir-Torre variant hereditary non-polyposis colon cancerChan Yoon Cheah, Ly Dsouza, Melissa W Taggart, et al.
International Journal of Molecular Sciences|September 23, 2017
The Diagnostic, Prognostic, and Therapeutic Utility of Molecular Testing in a Patient with Waldenstrom's MacroglobulinemiaCollin K Chin, Connull Leslie, Carolyn S Grove, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2019
Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapyCollin K Chin, Sara Hall, Celia Green, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2019
Management of patients with follicular lymphoma treated first line with obinutuzumabStephen Opat, Michael Dickinson, Chan Yoon Cheah, et al.
American Journal of Clinical Pathology|August 22, 2019
Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic LeukemiaBianca M Van Der Nest, Connull Leslie, David Joske, et al.
Acta Oncologica (Stockholm, Sweden)|March 20, 2020
Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomasTarec Christoffer El-Galaly, Chan Yoon Cheah, Daniel Kristensen, et al.
Blood|May 23, 2015
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphomaChan Yoon Cheah, Loretta J Nastoupil, Sattva S Neelapu, et al.
Blood Advances|May 7, 2021
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic reviewEdward J Bataillard, Chan Yoon Cheah, Matthew J Maurer, et al.
Neuro-Oncology|October 22, 2015
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphomaChan Yoon Cheah, Sarah Milgrom, Dai Chihara, et al.
British Journal of Haematology|July 30, 2016
High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphomaChan Yoon Cheah, David Joske, Gavin Cull, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pathology|May 27, 2015
Diffuse large B-cell lymphoma with microsatellite instability developing in the setting of Muir-Torre variant hereditary non-polyposis colon cancerChan Yoon Cheah, Ly Dsouza, Melissa W Taggart, et al.
International Journal of Molecular Sciences|September 23, 2017
The Diagnostic, Prognostic, and Therapeutic Utility of Molecular Testing in a Patient with Waldenstrom's MacroglobulinemiaCollin K Chin, Connull Leslie, Carolyn S Grove, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2019
Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapyCollin K Chin, Sara Hall, Celia Green, et al.
Asia-Pacific Journal of Clinical Oncology|May 7, 2019
Management of patients with follicular lymphoma treated first line with obinutuzumabStephen Opat, Michael Dickinson, Chan Yoon Cheah, et al.
American Journal of Clinical Pathology|August 22, 2019
Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic LeukemiaBianca M Van Der Nest, Connull Leslie, David Joske, et al.
Acta Oncologica (Stockholm, Sweden)|March 20, 2020
Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomasTarec Christoffer El-Galaly, Chan Yoon Cheah, Daniel Kristensen, et al.
Blood|May 23, 2015
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphomaChan Yoon Cheah, Loretta J Nastoupil, Sattva S Neelapu, et al.
Blood Advances|May 7, 2021
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic reviewEdward J Bataillard, Chan Yoon Cheah, Matthew J Maurer, et al.
Neuro-Oncology|October 22, 2015
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphomaChan Yoon Cheah, Sarah Milgrom, Dai Chihara, et al.
British Journal of Haematology|July 30, 2016
High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphomaChan Yoon Cheah, David Joske, Gavin Cull, et al.
Pageof 7